Skip to main content
. Author manuscript; available in PMC: 2017 Oct 13.
Published in final edited form as: Lancet Glob Health. 2017 Oct;5(10):e1017–e1025. doi: 10.1016/S2214-109X(17)30321-2

Table 1. Characteristics of bite victims who received counselling by an IBCM programme.

Rabies case classification of dogs Total population (n=115) p value

Confirmed (n=18) Probable (n=21) Suspected (n=29) Non-case (n=47)
Demographics

Men 15 (83%) 14 (67%) 14 (48%) 23 (49%) 66 (57%) 0.04
Age (years) 33 (3–87) 29 (0–72) 32 (5–80) 25 (1–70) 29 (0–87) ..

Department of residence

Artibonite 3 (17%) 2 (10%) 1 (3%) 1 (2%) 7 (6%) 0.16
Centre 3 (17%) 5 (24%) 2 (7%) 6 (13%) 16 (14%)
Ouest 12 (67%) 14 (67%) 26 (90%) 40 (85%) 92 (80%)

Health-care-seeking behaviours

Traditional healer 2 (11%) 3 (14) 2 (7%) 8 (17%) 15 (13%) 0.63
Sought medical care before IBCM counselling 8 (44%) 9 (43%) 26 (90%) 39 (83%) 82 (71%) <0.0001
Vaccination
 Recommended before IBCM counselling 4 (22%) 8 (38%) 14 (48%) 14 (30%) 40 (35%) 0.24
 Total recommended vaccination 17 (94%) 15 (71%) 27 (93%) 37 (79%) 96 (84%) 0.09
 Started before IBCM counselling 4 (22%) 8 (38%) 14 (48%) 14 (30%) 40 (35%) 0.24
 Total started vaccination 17 (94%) 14 (67%) 25 (86%) 35 (75%) 91 (79%) 0.11
 Vaccine series completed (≥4 doses) 15 (83%) 11 (52%) 10 (35%) 20 (43%) 56 (49%) 0.0081
 Number of vaccine doses received 4.3 (0-5) 3.9 (0-5) 3.0 (0-5) 3.5 (0-5) 37 (0-5) ..
 Received rabies immunoglobulin 2 of 17 (12%) 1 of 14 (7%) 4 of 25 (16%) 6 of 35 (17%) 12 of 91 (13%) 0.81
 Delay in starting vaccination (days) 4.5 (0-13) 1.5 (0-3) 1.5 (0-11) 2.9 (0-9) 2.5 (0-13) ..
 Adverse reactions to vaccination 2 of 17 (12%) 1 of 14 (7%) 0 3 of 35 (9%) 6 of 91 (7%) 0.43
IBCM programme afected treatment decisions 18 (100%) 16 (76%) 28 (97%) 45 (957%) 107 (93%) 0.0087

Data are number (%) or mean (range). IBCM=integrated bite case management.